Bioavailability and antagonization of the low molecular weight heparin CY 216 in man
- 15 November 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 44 (4) , 549-554
- https://doi.org/10.1016/0049-3848(86)90333-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- Anticoagulant and lipolytic effects of a low molecular weight heparin fractionThrombosis Research, 1985
- In Vivo Neutralization of Low-Molecular Weight Heparin Fraction CY 216 by ProtamineSeminars in Thrombosis and Hemostasis, 1985
- Inhibition of low molecular weight heparin by protamine chloride in vivoThrombosis Research, 1985
- Characterization of heparins by high-performance size exclusion liquid chromatographyJournal of Chromatography A, 1983
- A Comparison of two Heparin-Neutralizing Agents: Protamine and PolybreneScandinavian Journal of Clinical and Laboratory Investigation, 1960
- NEUTRALISATION OF ACTION OF HEPARIN BY PROTAMINEThe Lancet, 1939